Suchergebnisse - "Letter"

PubPharm (3.935)

1

The clearance rate of day 7 peripheral blood blasts (D7PBBs) can predict therapeutic effect for AML

enthalten in: Minerva endocrinologica | 2019

von Wu, H. | Zhao, X. | Cao, H. | +4

2

Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2019

von Luo, J. | Gu, D. | Lu, H. | +2

3

Acquired EGFR L718V Mutation and Loss of T790M-Mediated Resistance to Osimertinib in a Patient With NSCLC Who Responded to Afatinib

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2019

von Fang, W. | Gan, J. | Huang, Y. | +2

4

Depletion of regulatory FoxP3+ T cells in the pathogenesis of Stevens-Johnson syndrome induced by mogamulizumab

enthalten in: International journal of dermatology | 2019

von Amakata, M. | Teraki, Y.

5

Circulating unconventional T-cell subsets during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia

enthalten in: European journal of haematology | 2019

von Konuma, T. | Kohara, C. | Watanabe, E. | +5

6

BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias

enthalten in: Leukemia research | 2019

von Massé, A. | Roulin, L. | Pasanisi, J. | +18

7

Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab

enthalten in: Haematologica | 2019

von Cook, L. | Demontis, M. | Sagawe, S. | +10

8

Anti-leukemia effect of vitamin K3 is mediated through mitochondrial complexes I and II

enthalten in: Leukemia & lymphoma | 2019

von Ibrahim, M. | Mendis, N. | Roma, A. | +3

9

Strong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia - a prominent biomarker and potential target for anti-SLAMF7 antibody therapy

enthalten in: Leukemia & lymphoma | 2019

von Elmaagacli, A. | Salwender, H. | Jehn, C. | +6

10

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models

enthalten in: Leukemia & lymphoma | 2019

von Astorgues-Xerri, L. | Vázquez, R. | Odore, E. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[394]